An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC)

IMPORTANCE: It is unknown whether and to what degree trials submitted to the US FDA to support drug approval adhere to NCCN guideline-recommended care in their baseline and surveillance CNS imaging protocols. OBJECTIVE: We sought to characterize the frequency with which the trials cited in US FDA dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharp, John, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761278/
https://www.ncbi.nlm.nih.gov/pubmed/35034621
http://dx.doi.org/10.1186/s12885-022-09179-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761278/
https://www.ncbi.nlm.nih.gov/pubmed/35034621
http://dx.doi.org/10.1186/s12885-022-09179-y

Ejemplares similares